Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include HER2/EGFR in Cancer Research, Drug Transport and Resistance Mechanisms, Cancer Immunotherapy and Biomarkers, and Cancer Treatment and Pharmacology.
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension
Crushed deferasirox <scp>film‐coated</scp> tablets in pediatric patients with transfusional hemosiderosis: Results from a <scp>single‐arm</scp>, interventional phase 4 study (<scp>MIMAS</scp>)
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients